Revivo ordered to withdraw claims about supplement it can’t back up with ‘credible evidence’

20 October 2016 - 13:55 By Nomahlubi Jordaan
subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now
Image: Gallo Images/Thinkstock

Despite five rulings ordering Revivo‚ which claims to be “the world’s number one immune supplement”‚ to withdraw its claims of curing all ailments‚ the company is at it again‚ making the same assertion.

But Dr Harris Steinman did not take kindly to these claims and recently lodged a complaint with the Advertising Standards Authoriy (ASA) against an email advert Revivo has been circulating promoting its capsules.

The body of the advertisement reads: “They know Revivo works‚ that's why they tried to stop us...”.

“…Today Revivo is still available‚ and its [sic] still the worlds [sic] number 1 immune supplement. It is still working wonders for hundreds of thousands of people throughout the world. It's helping people achieve their dreams‚ live a happy and long life and removing the stress and worry that comes with being sick‚” the advertisement goes on to read.

Steinman‚ a consumer activist‚ argued that Revivo’s claims are not true‚ have not been backed up by any scientific evidence and are “aimed at purely luring consumers into buying the product”.

Revivo did not respond to the allegations‚ despite acknowledging receipt of the complaint from the ASA.

“It appears from the history with the ASA that the respondent has a pattern of making unsubstantiated claims and failing to comply with adverse rulings‚” the advertising authority held.

“Despite the complainant’s submission that he could find no credible evidence of such claims‚ and despite being afforded the opportunity to present any evidence it has to substantiate such claims‚ the respondent submitted nothing‚” ASA contended.

The ASA ruled that Revivo‚ yet again‚ withdraw its claims and that the advertisement must never be used again.

– TMG Digital

 

subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now